Supplementary Table from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma

Supplementary Table from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma

Supplementary Table from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma

Na minha lista:
Detalhes bibliográficos
Autor principal: Weijia Cai (15099353) (author)
Outros Autores: Mai Q. Nguyen (13146777) (author), Nicole A. Wilski (15099347) (author), Timothy J. Purwin (15073093) (author), Mégane Vernon (15084703) (author), Manoela Tiago (392395) (author), Andrew E. Aplin (14940036) (author)
Publicado em: 2025
Assuntos:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Clinical Research and Trials
Methods and Technology
Cell Death and Senescence
Drug Discovery Technologies
Screening strategies (assays and chemical libraries)
Drug Targets
Protein kinase & phosphatase drug targets
Immunology
Immune responses to cancer
Precision Medicine
Skin Cancers
Melanoma
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados